ghk-cu reviews Peptide Your experience with GHK-CU :

Triple-Hormone-Receptor Agonist Retatrutide for Obesity Weekly retatrutide injections (1 mg12 mg) resulted in weight reductions of 7.217.5% at 24 weeks and 8.724.2% at 48 weeks in subjects with overweight or obesity (without T2DM) in a phase II, double-blind, randomized, placebo-controlled [125]

Treatment modalities for PNIs include nerve autografts, nerve allografts, nerve transfers, end-to-side coaptation, and nerve conduits

Approximately one year later, he experienced a severe worsening of his previously very mild neuropathy, and lab evaluation yielded a serum B12 of 220 pmol/l (which is normal, remember!?), but an elevated serum MMA of 1300 nmol/l, supporting the existence of true B12 deficiency

The B-12 test I had was the one they use to catch early and mild cases

Quick Takeaways What it is: A synthetic peptide fragment derived from human growth hormone (amino acids 176191)